Skip to main content
Open Access Publications from the University of California

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.

  • Author(s): Sharma, Padmanee
  • Hu-Lieskovan, Siwen
  • Wargo, Jennifer A
  • Ribas, Antoni
  • et al.

Cancer immunotherapy can induce long lasting responses in patients with metastatic cancers of a wide range of histologies. Broadening the clinical applicability of these treatments requires an improved understanding of the mechanisms limiting cancer immunotherapy. The interactions between the immune system and cancer cells are continuous, dynamic, and evolving from the initial establishment of a cancer cell to the development of metastatic disease, which is dependent on immune evasion. As the molecular mechanisms of resistance to immunotherapy are elucidated, actionable strategies to prevent or treat them may be derived to improve clinical outcomes for patients.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View